166 related articles for article (PubMed ID: 24732345)
1. The C in TORCH: a cost-effective alternative to screening small-for-gestational-age infants.
Wei D; Sardesai SR; Barton L
Neonatology; 2014; 106(1):24-9. PubMed ID: 24732345
[TBL] [Abstract][Full Text] [Related]
2. Utility of routine urine CMV PCR and total serum IgM testing of small for gestational age infants: a single center review.
Espiritu MM; Bailey S; Wachtel EV; Mally PV
J Perinat Med; 2018 Jan; 46(1):81-86. PubMed ID: 28803228
[TBL] [Abstract][Full Text] [Related]
3. Is routine TORCH screening and urine CMV culture warranted in small for gestational age neonates?
van der Weiden S; de Jong EP; Te Pas AB; Middeldorp JM; Vossen AC; Rijken M; Walther FJ; Lopriore E
Early Hum Dev; 2011 Feb; 87(2):103-7. PubMed ID: 21145674
[TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness of a cytomegalovirus screening strategy in neonates born after 34 weeks small for gestational age.
Merino-Hernández A; Sánchez-Barriopedro L; Villar-Castro S; Aguado-Del Hoyo A; Marsinyach-Ros I; Sánchez-Luna M
An Pediatr (Engl Ed); 2023 Jan; 98(1):41-47. PubMed ID: 36528494
[TBL] [Abstract][Full Text] [Related]
5. Screening investigations in small-for-gestational-age near-term and term infants.
Krishnamurthy MB; Popiel A; Malhotra A
Eur J Pediatr; 2017 Dec; 176(12):1707-1712. PubMed ID: 28993892
[TBL] [Abstract][Full Text] [Related]
6. Routine TORCH screening is not warranted in neonates with subependymal cysts.
van der Weiden S; Steggerda SJ; Te Pas AB; Vossen AC; Walther FJ; Lopriore E
Early Hum Dev; 2010 Apr; 86(4):203-7. PubMed ID: 20227842
[TBL] [Abstract][Full Text] [Related]
7. Yield and costs of screening growth-retarded infants for torch infections.
Khan NA; Kazzi SN
Am J Perinatol; 2000; 17(3):131-5. PubMed ID: 11012137
[TBL] [Abstract][Full Text] [Related]
8. Urine is superior to saliva when screening for postnatal CMV infections in preterm infants.
Gunkel J; Wolfs TF; Nijman J; Schuurman R; Verboon-Maciolek MA; de Vries LS; Murk JL
J Clin Virol; 2014 Sep; 61(1):61-4. PubMed ID: 24986439
[TBL] [Abstract][Full Text] [Related]
9. Is routine TORCH screening warranted in neonates with lenticulostriate vasculopathy?
de Jong EP; Lopriore E; Vossen AC; Steggerda SJ; Te Pas AB; Kroes AC; Walther FJ
Neonatology; 2010; 97(3):274-8. PubMed ID: 19887856
[TBL] [Abstract][Full Text] [Related]
10. Neonatal screening for congenital cytomegalovirus infection in preterm and small for gestational age infants.
Lorenzoni F; Lunardi S; Liumbruno A; Ferri G; Madrigali V; Fiorentini E; Forli F; Berrettini S; Boldrini A; Ghirri P
J Matern Fetal Neonatal Med; 2014 Oct; 27(15):1589-93. PubMed ID: 24328547
[TBL] [Abstract][Full Text] [Related]
11. Congenital cytomegalovirus infection and small for gestational age infants.
Simonazzi G; Curti A; Murano P; Cervi F; Contoli M; Lazzarotto T; Capretti MG; Rizzo N; Guerra B
Prenat Diagn; 2014 Aug; 34(8):765-9. PubMed ID: 24665022
[TBL] [Abstract][Full Text] [Related]
12. TORCH (toxoplasmosis, rubella, cytomegalovirus, and herpes simplex virus) screening of small for gestational age and intrauterine growth restricted neonates: efficacy study in a single institute in Korea.
Chung MH; Shin CO; Lee J
Korean J Pediatr; 2018 Apr; 61(4):114-120. PubMed ID: 29713357
[TBL] [Abstract][Full Text] [Related]
13. Universal neonatal cytomegalovirus screening using saliva - report of clinical experience.
Barkai G; Ari-Even Roth D; Barzilai A; Tepperberg-Oikawa M; Mendelson E; Hildesheimer M; Kuint J
J Clin Virol; 2014 Aug; 60(4):361-6. PubMed ID: 24881490
[TBL] [Abstract][Full Text] [Related]
14. [Screening for cytomegalovirus infection in very low birth weight infants].
Álvarez Domínguez E; Figueras Aloy J; Botet Mussons F; Marcos Maeso MA; Pérez Fernández JM
An Pediatr (Barc); 2013 Jul; 79(1):3-9. PubMed ID: 23228440
[TBL] [Abstract][Full Text] [Related]
15. Screening small for gestational age babies for congenital infection.
Primhak RA; Simpson RM
Clin Pediatr (Phila); 1982 Jul; 21(7):417-20. PubMed ID: 6282523
[TBL] [Abstract][Full Text] [Related]
16. Urine viral load and correlation with disease severity in infants with congenital or postnatal cytomegalovirus infection.
Nijman J; van Loon AM; de Vries LS; Koopman-Esseboom C; Groenendaal F; Uiterwaal CS; Verboon-Maciolek MA
J Clin Virol; 2012 Jun; 54(2):121-4. PubMed ID: 22421537
[TBL] [Abstract][Full Text] [Related]
17. The Utility of Maternal TORCH Screening Due to Obstetrical Indications in Detecting Congenital Infections: A Retrospective Observational Study.
Abu Shqara R; Or S; Abu Zraki A; Rizik J; Glikman D; Rechnitzer H; Lowenstein L; Frank Wolf M
Pediatr Infect Dis J; 2024 Jan; 43(1):69-73. PubMed ID: 37725823
[TBL] [Abstract][Full Text] [Related]
18. Postnatally acquired cytomegalovirus infection in preterm infants: a prospective study on risk factors and cranial ultrasound findings.
Nijman J; de Vries LS; Koopman-Esseboom C; Uiterwaal CS; van Loon AM; Verboon-Maciolek MA
Arch Dis Child Fetal Neonatal Ed; 2012 Jul; 97(4):F259-63. PubMed ID: 22247412
[TBL] [Abstract][Full Text] [Related]
19. Prenatal diagnosis of congenital cytomegalovirus infection in 189 pregnancies with known outcome.
Enders G; Bäder U; Lindemann L; Schalasta G; Daiminger A
Prenat Diagn; 2001 May; 21(5):362-77. PubMed ID: 11360277
[TBL] [Abstract][Full Text] [Related]
20. Is saliva as reliable as urine for detection of cytomegalovirus DNA for neonatal screening of congenital CMV infection?
Yamamoto AY; Mussi-Pinhata MM; Marin LJ; Brito RM; Oliveira PF; Coelho TB
J Clin Virol; 2006 Jul; 36(3):228-30. PubMed ID: 16750653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
